CEO: | Adrian Kinkaid |
Chairman: | Simon Gordon Douglas |
Chief Scientific Officer: | Richard John Buick |
Non-Executive Dir: | Matthew Baker, Colin Walsh |
Address: | Springbank Industrial Estate, 1 Springbank Rd, Dunmurry, Belfast, United Kingdom, BT17 0QL |
Website: | https://www.fusionantibodies.com/ |
Sector: | Health Care(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BDQZGK16 |
Currency | UK Pounds |
Share Price | 6.70p |
Change Today | -0.15p |
% Change | -2.19 % |
52 Week High | 10.20 |
52 Week Low | 2.90 |
Volume | 246,277 |
Shares Issued | 113.66m |
Market Cap | £7.61m |
RiskGrade | 464 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:26 | 20,000 @ 6.50p |
16:19 | 3 @ 6.90p |
11:29 | 712 @ 7.09p |
10:36 | 20,000 @ 6.55p |
10:28 | 29,630 @ 6.54p |
Chair | Simon Gordon Douglas |
CEO | Adrian Kinkaid |
You are here: research